$7.97
0.081.01%
Last update: Nov 6, 4:00 PM
Prothena Corp PLC (PRTA) Stock Price, Quote, News & History
PRTANASDAQ
Prothena Corporation plc (NASDAQ: PRTA) is reportedly talking to advisors, potentially preparing for a sale.
You can purchase shares of Prothena Corp (NASDAQ:PRTA) through any online brokerage.
Other companies in Prothena Corp’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Prothena Corp has a consensus price target of $27.82.
The stock price for Prothena Corp (NASDAQ: PRTA) is $7.97 last updated November 6, 2026 at 4:00 PM EST.
There are no upcoming dividends for Prothena Corp.
Prothena Corp does not have any upcoming earnings scheduled.
There is no upcoming split for Prothena Corp.
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral...
